市場調查報告書

干擾素全球市場:新型冠狀病毒感染疾病(COVID-19)的影響與成長(2020年∼2030年)

Interferons Global Market Report 2020-30: Covid 19 Implications and Growth

出版商 The Business Research Company 商品編碼 932427
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
干擾素全球市場:新型冠狀病毒感染疾病(COVID-19)的影響與成長(2020年∼2030年) Interferons Global Market Report 2020-30: Covid 19 Implications and Growth
出版日期: 2020年04月16日內容資訊: 英文
簡介

本報告調查了COVID-19病毒對干擾素市場的影響,並提供企業的策略負責人,行銷負責人,上級管理人員有助於評估在治療COVID-19的患者中發揮重要作用之干擾素的需求趨勢所需的必要信息。

本報告提供全球干擾素市場調查,提供新型冠狀病毒感染疾病(COVID-19)的影響與今後展望,干擾素的最大的市場與急速增長的市場,全般的到定向經濟趨勢和人口動態,接近市場的關聯性,今後的市場的要素等從分析,2015年2019年從趨勢與2019年開始2030年與為止的預測,世界各地區和各國的市場分析,競爭情形主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 干擾素市場特徵

第3章 干擾素的市場規模與成長

  • 2015年∼2019年的市場動向
    • 促進市場成長的要素
    • 阻礙市場成長要素
  • 2019年∼2023年,2025年,2030年的市場預測
    • 促進市場成長的要素
    • 阻礙市場成長要素

第4章 干擾素的市場區隔

  • 各類型市場迄今的動向和今後的預測
    • inteferon'arufa
    • β型干擾素
    • 干擾素伽馬
  • 各用途市場的迄今的動向和今後的預測
    • B型肝炎
    • C型肝炎
    • 黑色素瘤
    • 白血病
    • 多發性硬化症
    • 腎細胞癌症

第5章 各地區,各國市場分析

  • 各地區市場迄今的動向和今後的預測
  • 各國市場的迄今的動向和今後的預測

第6章 亞太地區市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第7章 中國市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第8章 印度市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第9章 日本市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第10章 澳洲市場

  • 各類型市場迄今的動向和今後的預測

第11章 印尼市場

  • 各類型市場迄今的動向和今後的預測

第12章 韓國市場

  • 各類型市場迄今的動向和今後的預測

第13章 西歐市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第14章 英國市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第15章 德國市場

  • 各類型市場迄今的動向和今後的預測

第16章 法國市場

  • 各類型市場迄今的動向和今後的預測

第17章 東歐市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第18章 俄羅斯市場

  • 各類型市場迄今的動向和今後的預測

第19章 北美市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第20章 美國市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第21章 南美市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第22章 巴西市場

  • 各類型市場迄今的動向和今後的預測

第23章 中東市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第24章 非洲市場

  • 市場概要
  • 各類型市場迄今的動向和今後的預測

第25章 競爭情形和企業簡介

  • 競爭情形
  • 主要企業的簡介
    • Roche
    • Merck
    • Bristol-Myers Squibb
    • Biogen Inc
    • Bayer AG

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 未來展望和未來性分析

第29章 附錄

  • 簡稱
  • 貨幣
目錄

Interferons Market Global Report 2020: Covid 19 Implications and Growth from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for interferons which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the interferons? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Interferons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider interferons market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The interferons market section of the report gives context. It compares the interferons market with other segments of the interferons market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, interferons indicators comparison.

Scope

Markets Covered: 1) By Type: Inteferon Alpha; Inteferon Beta; Inteferon Gamma

2) By Application: Hepatitis B; Hepatitis C; Melanoma; Leukemia; Multiple Sclerosis; Renal Cell Carcinoma

Companies Mentioned: Roche; Merck; Bristol-Myers Squibb; Biogen Inc; Bayer AG

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA and Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Interferons Market Characteristics

3. Interferons Market Size And Growth

  • 3.1. Global Interferons Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Interferons Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Interferons Market Segmentation

  • 4.1. Global Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Inteferon Alpha
    • Inteferon Beta
    • Inteferon Gamma
  • 4.2. Global Interferons Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hepatitis B
    • Hepatitis C
    • Melanoma
    • Leukemia
    • Multiple Sclerosis
    • Renal Cell Carcinoma

5. Interferons Market Regional And Country Analysis

  • 5.1. Global Interferons Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Interferons Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Interferons Market

  • 6.1. Asia-Pacific Interferons Market Overview
  • 6.2. Asia-Pacific Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Interferons Market

  • 7.1. China Interferons Market Overview
  • 7.2. China Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Interferons Market

  • 8.1. India Interferons Market Overview
  • 8.2. India Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Interferons Market

  • 9.1. Japan Interferons Market Overview
  • 9.2. Japan Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Interferons Market

  • 10.1. Australia Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Interferons Market

  • 11.1. Indonesia Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Interferons Market

  • 12.1. South Korea Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Interferons Market

  • 13.1. Western Europe Interferons Market Overview
  • 13.2. Western Europe Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Interferons Market

  • 14.1. UK Interferons Market Overview
  • 14.2. UK Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Interferons Market

  • 15.1. Germany Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Interferons Market

  • 16.1. France Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Interferons Market

  • 17.1. Eastern Europe Interferons Market Overview
  • 17.2. Eastern Europe Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Interferons Market

  • 18.1. Russia Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Interferons Market

  • 19.1. North America Interferons Market Overview
  • 19.2. North America Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Interferons Market

  • 20.1. USA Interferons Market Overview
  • 20.2. USA Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Interferons Market

  • 21.1. South America Interferons Market Overview
  • 21.2. South America Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Interferons Market

  • 22.1. Brazil Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Interferons Market

  • 23.1. Middle East Interferons Market Overview
  • 23.2. Middle East Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Interferons Market

  • 24.1. Africa Interferons Market Overview
  • 24.2. Africa Interferons Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Interferons Market Competitive Landscape And Company Profiles

  • 25.1. Interferons Market Competitive Landscape
  • 25.2. Interferons Market Company Profiles
    • 25.2.1. Roche
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Merck
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bristol-Myers Squibb
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Biogen Inc
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Bayer AG
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Interferons Market

27. Interferons Market Trends And Strategies

28. Interferons Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer